Your browser doesn't support javascript.
loading
THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents.
Greiner, Jeanette; Schrappe, Martin; Claviez, Alexander; Zimmermann, Martin; Niemeyer, Charlotte; Kolb, Reinhard; Eberl, Wolfgang; Berthold, Frank; Bergsträsser, Eva; Gnekow, Astrid; Lassay, Elisabeth; Vorwerk, Peter; Lauten, Melchior; Sauerbrey, Axel; Rischewski, Johannes; Beilken, Andreas; Henze, Günter; Korte, Wolfgang; Möricke, Anja.
  • Greiner J; Children's Hospital of Eastern Switzerland, Hematology and Oncology Department, St. Gallen, Switzerland jeanette.greiner@kispisg.ch.
  • Schrappe M; Department of Pediatrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Claviez A; Department of Pediatrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Zimmermann M; Department of Pediatric Hematology and Oncology, Hannover Medical School, Germany.
  • Niemeyer C; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center - Faculty of Medicine, University of Freiburg, Germany.
  • Kolb R; Department of Pediatrics, Zentrum für Kinder- und Jugendmedizin, Klinikum Oldenburg GmbH, Germany.
  • Eberl W; Institute for Clinical Transfusion Medicine and Children's Hospital, Klinikum Braunschweig GmbH, Germany.
  • Berthold F; Department of Pediatric Hematology and Oncology, Children's Hospital, University of Cologne, Germany.
  • Bergsträsser E; Department of Pediatric Oncology, University Children's Hospital, Zurich, Switzerland.
  • Gnekow A; Hospital for Children and Adolescents, Klinikum Augsburg, Germany.
  • Lassay E; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Germany.
  • Vorwerk P; Pediatric Oncology, Otto von Guericke University Children's Hospital, Magdeburg, Germany.
  • Lauten M; University Hospital Schleswig-Holstein, Department of Pediatrics, University of Lübeck, Germany.
  • Sauerbrey A; HELIOS Children's Hospital GmbH, Erfurt, Germany.
  • Rischewski J; Department of Oncology/Hematology, Children's Hospital, Cantonal Hospital Lucerne, Switzerland.
  • Beilken A; Department of Pediatric Hematology and Oncology, Hannover Medical School, Germany.
  • Henze G; Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin Berlin, Germany.
  • Korte W; Center for Laboratory Medicine and Hemostasis and Hemophilia Center, St. Gallen, Switzerland.
  • Möricke A; Department of Pediatrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
Haematologica ; 104(4): 756-765, 2019 04.
Article en En | MEDLINE | ID: mdl-30262570
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tromboembolia / Heparina / Antitrombinas / Heparina de Bajo-Peso-Molecular / Leucemia-Linfoma Linfoblástico de Células Precursoras / Quimioterapia de Inducción Tipo de estudio: Clinical_trials / Observational_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tromboembolia / Heparina / Antitrombinas / Heparina de Bajo-Peso-Molecular / Leucemia-Linfoma Linfoblástico de Células Precursoras / Quimioterapia de Inducción Tipo de estudio: Clinical_trials / Observational_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Año: 2019 Tipo del documento: Article